AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/113

Authors: BRICE P GODIN S LIBERT O MAROLLEAU JP MAKKI J EXTRA JM FAURE P GISSELBRECHT C
Citation: P. Brice et al., EFFECT OF LENOGRASTIN ON THE COST OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PRELIMINARY COMMUNICATION, PharmacoEconomics, 7(3), 1995, pp. 238-241

Authors: GISSELBRECHT C FERME C
Citation: C. Gisselbrecht et C. Ferme, PROGNOSTIC FACTORS IN ADVANCED HODGKINS-DISEASE - PROBLEMS AND PITFALLS - TOWARDS AN INTERNATIONAL PROGNOSTIC INDEX, Leukemia & lymphoma, 15, 1995, pp. 23-24

Authors: GISSELBRECHT C
Citation: C. Gisselbrecht, PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND TREATMENT OF NON-HODGKINS-LYMPHOMA, European journal of cancer, 31A, 1995, pp. 10-10

Authors: GABARRE J LEPAGE E THYSS A TUBIANA R BASTION Y SCHLAIFER D SEBBAN C RIBRAG V FERERES M RAPHAEL M GISSELBRECHT C
Citation: J. Gabarre et al., CHEMOTHERAPY COMBINED WITH ZIDOVUDINE AND GM-CSF IN HUMAN IMMUNODEFICIENCY VIRUS-RELATED NON-HODGKINS-LYMPHOMA, Annals of oncology, 6(10), 1995, pp. 1025-1032

Authors: MOUNIER N PAUTIER P DEKERVILER E KERNEIS Y GISSELBRECHT C BRICE P
Citation: N. Mounier et al., LYMPHOPLASMOCYTIC MALIGNANT-LYMPHOMA PRESENTING WITH SPINAL EPIDURAL INVOLVEMENT - 4 REPORTS OF THIS UNCOMMON LESION, American journal of hematology, 50(4), 1995, pp. 316-317

Authors: GISSELBRECHT C
Citation: C. Gisselbrecht, TREATMENT OF ADULT INTERMEDIATE GRADE NON -HODGKINS-LYMPHOMA, La Revue de medecine interne, 16(8), 1995, pp. 608-615

Authors: LOTZ JP PENE F BOULEUC C ANDRE T GISSELBRECHT C BONNAK H MERAD Z ESTESO A MICCIOBELLAICHE A AVENIN D DONSIMONI R FIRMIN C GLIGOROV J MORVAN F PHILIPPE G CHEVALLIER D HING JM SEKNAZI C PROT C BENMILOUD M OUDARD S CHOPIERRICHAUD J GEROTA J IZRAEL V
Citation: Jp. Lotz et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STE M-CELL SUPPORT FOR THE TREATMENT OF SOLID TUMORS IN ADULTS .2. PRINCIPLES, ORGANIZATION AND APPLICATION TO THE TREATMENT OF GERM-CELL, TROPHOBLASTIC, MAMMARY, OVARIAN AND SMALL-CELL BRONCHOGENIC CANCERS, La Revue de medecine interne, 16(2), 1995, pp. 150-162

Authors: LOTZ JP PENE F BOULEUC C ANDRE T GISSELBRECHT C BONNAK H MERAD Z ESTESO A MICCIOBELLAICHE A AVENIN D DONSIMONI R FIRMIN C GLIGOROV J CHEVALLIER D SEKNAZI C PROT C BENMILOUD M OUDARD S CHOPIERRICHAUD J IZRAEL V
Citation: Jp. Lotz et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STE M-CELL SUPPORT FOR THE TREATMENT OF SOLID TUMORS IN ADULTS .1., La Revue de medecine interne, 16(1), 1995, pp. 43-54

Authors: PHILIP T GUGLIELMI C HAGENBEEK A SOMERS R VANDERLELIE H BRON D SONNEVELD P GISSELBRECHT C CAHN JY HAROUSSEAU JL COIFFIER B BIRON P MANDELLI F CHAUVIN F
Citation: T. Philip et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS COMPARED WITH SALVAGE CHEMOTHERAPY IN RELAPSES OF CHEMOTHERAPY-SENSITIVE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 333(23), 1995, pp. 1540-1545

Authors: GISSELBRECHT C
Citation: C. Gisselbrecht, INTENSIVE CHEMOTHERAPY WITH BONE-MARROW G RAFT - ASSESSMENT AND LIMITS - THE FUTURE, Bulletin du cancer, 82, 1995, pp. 51-52

Authors: BASTION Y BRICE P HAIOUN C SONET A SALLES G MAROLLEAU JP ESPINOUSE D REYES F GISSELBRECHT C COIFFIER B
Citation: Y. Bastion et al., INTENSIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN 60 PATIENTS WITH POOR-PROGNOSIS FOLLICULAR LYMPHOMA, Blood, 86(8), 1995, pp. 3257-3262

Authors: HAIOUN C LEPAGE E GISSELBRECHT C BASTION Y DOYEN C PLANTIER I SCHLAIFER D TILLY H DECONINCK E BORDESSOULE D GAULARD P REYES F
Citation: C. Haioun et al., AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 96 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL, Blood, 86(10), 1995, pp. 833-833

Authors: SEBBAN C WENDUM D GAULARD P COIFFIER B CAZALS D GABARRE J CASANOVAS O BOUABDALLAH R JAUBERT J FILLET G DIEBOLD J GISSELBRECHT C
Citation: C. Sebban et al., FOLLICULAR LARGE-CELL LYMPHOMA (FLCL) TREATED BY INTENSIVE CHEMOTHERAPY - AN ANALYSIS OF 89 CASES INCLUDED IN THE LNH87 TRIAL END COMPARISON WITH THE OUTCOME OF DIFFUSE LARGE-CELL LYMPHOMA (DLCL), Blood, 86(10), 1995, pp. 1746-1746

Authors: HAIOUN C LEPAGE E GISSELBRECHT C COIFFIER B BOSLY A DUPRIEZ B NOUVEL C TILLY H LEDERLIN P BIRON P BRIERE J GAULARD P REVES F
Citation: C. Haioun et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) VERSUS SEQUENTIAL CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) IN FIRST COMPLETE REMISSION (CR) - A STUDY OF 542 PATIENTS (LNH87-2 PROTOCOL), Blood, 86(10), 1995, pp. 1816-1816

Authors: HAGENBEEK A GUGLIELMI C CHAUVIN F VANDERLELY J BRON D SONNEVELD P GISSELBRECHT C CAHN JY HAROUSSEAU JL COIFFIER B BIRON P SOMERS R PHILIP T
Citation: A. Hagenbeek et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CONVENTIONAL CHEMOTHERAPY IN PATIENTS WITH RELAPSED DIFFUSE NONHODGKINS LYMPHOMA - RESULTS FROM A PROSPECTIVE, RANDOMIZED PHASE-III CLINICAL-TRIAL IN 216 PATIENTS (THE PARMA STUDY), Blood, 86(10), 1995, pp. 1817-1817

Authors: ANDRE M HENRYAMAR M BLAISE D COLOMBAT P FLEURY J MILPIED N GAHN JY PICO JL BASTION Y KUENTZ M BIRON P FERME C GISSELBRECHT C
Citation: M. Andre et al., INCIDENCE OF 2ND CANCERS (SC) AND CAUSES OF DEATH AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR HODGKINS-DISEASE (HD), Blood, 86(10), 1995, pp. 1826-1826

Authors: MAROLLEAU JP BACCARD M FLAGEUL B RYBOJAD M LAROCHE L VEROLA O BRANDELY M MOREL P GISSELBRECHT C
Citation: Jp. Marolleau et al., HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN ADVANCED CUTANEOUS T-CELL LYMPHOMA, Archives of dermatology, 131(5), 1995, pp. 574-579

Authors: GEISSMANN F DEROUIN F MAROLLEAU JP GISSELBRECHT C BRICE P
Citation: F. Geissmann et al., DISSEMINATED TOXOPLASMOSIS FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Clinical infectious diseases, 19(4), 1994, pp. 800-801

Authors: RACADOT E SEBBAN C BOUCHEIX C DAVID B ATTAL M REIFFERS J GISSELBRECHT C VERNANT J TROUSSARD X HERVE P FIERE D
Citation: E. Racadot et al., AUTOLOGOUS BMT FOR POSTREMISSION THERAPY IN ADULT ALL - AN IMMUNOLOGICAL APPROACH, Leukemia & lymphoma, 13, 1994, pp. 95-98

Authors: GISSELBRECHT C
Citation: C. Gisselbrecht, CHEMOTHERAPY DOSE INTENSITY FACILITATED BY USE OF LENOGRASTIM - IMPLICATIONS FOR QUALITY-OF-LIFE AND SURVIVAL, European journal of cancer, 30A, 1994, pp. 30-33

Authors: TREDANIEL J PEILLON I FERME C BRICE P GISSELBRECHT C HIRSCH A
Citation: J. Tredaniel et al., ENDOBRONCHIAL PRESENTATION OF HODGKINS-DISEASE - A REPORT OF 9 CASES AND REVIEW OF THE LITERATURE, The European respiratory journal, 7(10), 1994, pp. 1852-1855

Authors: BRICE P GODIN S LIBERT O MAROLLEAU JP MAKKI J EXTRA JM FAURE P GISSELBRECHT C
Citation: P. Brice et al., EFFECT OF GRANULOCYTE GROWTH-FACTOR ON TH E COST OF BONE-MARROW AUTOGRAFTS IN ONCOHAEMATOLOGY, La Presse medicale, 23(33), 1994, pp. 1512-1515

Authors: HAIOUN C LEPAGE E GISSELBRECHT C COIFFIER B BOSLY A TILLY H MOREL P NOUVEL C HERBRECHT R DAGAY MF GAULARD P REYES F
Citation: C. Haioun et al., COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH SEQUENTIAL CHEMOTHERAPY FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA IN FIRST COMPLETE REMISSION - A STUDY OF 464 PATIENTS, Journal of clinical oncology, 12(12), 1994, pp. 2543-2551

Authors: GISSELBRECHT C BRICE P
Citation: C. Gisselbrecht et P. Brice, UTILIZATION OF PERIPHERAL-BLOOD STEM-CELL S IN INTENSIVE CHEMOTHERAPYOF LYMPHOMAS, Pathologie et biologie, 42(10), 1994, pp. 972-973

Authors: EXTRA JM ESPIE M BOURSTYN E DEROQUANCOURT A MAYLIN C GISSELBRECHT C MARTY M
Citation: Jm. Extra et al., HIGH-DOSE INDUCTION CHEMOTHERAPY (SIM-85) IN INFLAMMATORY BREAST-CANCER, Pathologie et biologie, 42(1), 1994, pp. 17-17
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>